Topics covered: Stable Utilization and Personal Health Expenditures, Multinational Penetration in Emerging Markets, Medical Device Excise Tax, Continued Pricing Pressure
Companies covered: Unilever NV (NYSE:UL), Tyson Foods, Inc. (NYSE:TSN), Sara Lee Corp., J.M. Smucker Company (The) (NYSE:SJM), Smithfield Foods Inc., Ralcorp Holdings Inc., Pepsico, Inc. (NASDAQ:PEP), McCormick & Company, Incorporated (NYSE:MKC), Kraft Foods Inc., Kellogg Company (NYSE:K), Hershey Company (The) (NYSE:HSY), Hormel Foods Corporation (NYSE:HRL), HJ Heinz Co., Hanesbrands Inc. (NYSE:HBI), General Mills, Inc. (NYSE:GIS), Dean Foods Company (NYSE:DF), Campbell Soup Company (NYSE:CPB), Conagra Brands Inc. (NYSE:CAG), ABIOMED, Inc. (NASDAQ:ABMD), Volcano Corporation (NASDAQ:VOLC), Thoratec Corporation (NASDAQ:THOR), St. Jude Medical, Inc. (NYSE:STJ), Medtronic, Inc. (NYSE:MDT), Heartware International, Inc. (NASDAQ:HTWR), Edwards Lifesciences Corporation (NYSE:EW), DexCom, Inc. (NASDAQ:DXCM), Cyberonics, Inc. (NASDAQ:CYBX), Boston Scientific Corporation (NYSE:BSX), Amazon.com, Inc. (NASDAQ:AMZN), Walmart Inc. (NYSE:WMT), Walgreen Co., United Natural Foods, Inc. (NASDAQ:UNFI), Sysco Corporation (NYSE:SYY), Safeway Inc. (NYSE:SWY), Smart Balance, Inc, Ruth's Hospitality Group, Inc. (NASDAQ:RUTH), Ruddick Corp., MedcoHealth Solutions Inc., Kroger Company (The) (NYSE:KR), The Hain Celestial Group, Inc. (NASDAQ:HAIN), Express Scripts Holding Company (NASDAQ:ESRX), CVS Health Corporation (NYSE:CVS), Costco Wholesale Corporation (NASDAQ:COST), Stryker Corporation (NYSE:SYK), General Electric Company (NYSE:GE), Covidien Ltd. (NYSE:COV), Becton, Dickinson and Company (NYSE:BDX), C.R. Bard, Inc. (NYSE:BCR), Baxter International Inc. (NYSE:BAX), Tyco International plc (NYSE:TYC), Johnson & Johnson (NYSE:JNJ), Cardinal Health, Inc. (NYSE:CAH), Mindray Medical International Limited (NYSE:MR), Craft Brewers Alliance, Inc., Synutra International, Inc. (NASDAQ:SYUT), EDAP TMS S.A. (NASDAQ:EDAP), Dynatronics Corporation (NASDAQ:DYNT), PhotoMedex, Inc. (NASDAQ:PHMD), Natus Medical Incorporated (NASDAQ:BABY)
